| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.06B | +9.0% |
| Cost of Revenue | $688.8M | +1.5% |
| R&D Expense | $1.07B | +12.6% |
| SG&A Expense | $512.4M | +49.2% |
| Operating Income | -$125.7M | -23.6% |
| Pre-tax Income | -$16.4M | +80.9% |
| Income Tax | $19.2M | +89.7% |
| Net Income | -$35.6M | +62.9% |
| EPS (Basic) | -$0.05 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.36B | -15.5% |
| Accounts Receivable | $763.2M | +12.0% |
| Current Assets | $3.34B | -3.4% |
| Total Assets | $3.59B | -6.9% |
| Current Liabilities | $317.1M | -16.7% |
| Total Liabilities | $503.7M | -13.3% |
| Stockholders' Equity | $3.09B | -5.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $613.0M | +30.6% |
| Investing Cash Flow | -$37.0M | +71.2% |
| Financing Cash Flow | -$826.8M | -455.1% |
| +64.3% |
| EPS (Diluted) | -$0.05 | +64.3% |